Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Cash & Equivalents (2016 - 2025)

Avalon GloboCare (ALBT) has 10 years of Cash & Equivalents data on record, last reported at $333931.0 in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 67.4% year-over-year to $333931.0; the TTM value through Sep 2025 reached $333931.0, down 67.4%, while the annual FY2024 figure was $2.9 million, 900.81% up from the prior year.
  • Cash & Equivalents reached $333931.0 in Q3 2025 per ALBT's latest filing, up from $201532.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.9 million in Q3 2022 and bottomed at $200572.0 in Q2 2024.
  • Average Cash & Equivalents over 5 years is $1.0 million, with a median of $685304.0 recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: crashed 91.32% in 2023, then soared 900.81% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $807538.0 in 2021, then soared by 146.54% to $2.0 million in 2022, then plummeted by 85.66% to $285400.0 in 2023, then skyrocketed by 900.81% to $2.9 million in 2024, then plummeted by 88.31% to $333931.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $333931.0 in Q3 2025, $201532.0 in Q2 2025, and $1.4 million in Q1 2025.